Trials / Completed
CompletedNCT00608829
GORE TAG® Thoracic Endoprosthesis - 45 mm for the Treatment of Aneurysms of the Descending Thoracic Aorta
Evaluation of the GORE TAG® Thoracic Endoprosthesis - 45 mm for the Primary Treatment of Aneurysms of the Descending Thoracic Aorta
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- W.L.Gore & Associates · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to assess the safety and efficacy of the 45 mm TAG device in subjects with aneurysms of the descending thoracic aorta.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | GORE TAG® Thoracic Endoprosthesis | Implant |
Timeline
- Start date
- 2007-02-01
- Primary completion
- 2009-08-01
- Completion
- 2014-09-01
- First posted
- 2008-02-06
- Last updated
- 2015-03-05
- Results posted
- 2010-09-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00608829. Inclusion in this directory is not an endorsement.